InMed Pharmaceuticals Inc... (INM)
NASDAQ: INM
· Real-Time Price · USD
2.29
0.03 (1.33%)
At close: Oct 03, 2025, 3:59 PM
2.24
-2.18%
After-hours: Oct 03, 2025, 06:47 PM EDT
InMed Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 1.3M | 1.27M | 1.11M | 1.26M | 1.75M | 1.59M | 1.64M | 1.22M | 3.06M | 1.4M | 631.22K | 439.74K | 662.79K | 386.82K | 337.86K | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 727.88K | 1.1M | 650.2K | 768.51K | 1.12M | 1.2M | 1.21M | 1.19M | 981.23K | 1.14M | 454.98K | 1.11M | 341.26K | 159.07K | 195.68K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 576.52K | 177.44K | 460.46K | 491.67K | 637.41K | 392.8K | 429.65K | 28.77K | 2.08M | 260.38K | 176.24K | -673.1K | 321.52K | 227.75K | 142.18K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.79M | -2.08M | -2.15M | -1.69M | -2.75M | -2.44M | -2.26M | n/a | -683.92K | -2.91M | -3M | -4.77M | -3.92M | -4.42M | -5.5M | -3.67M | -4.09M | -3.94M | -2.47M | -1.56M |
Interest Income | 51.9K | 16.64K | 30.52K | 56.83K | 141.74K | 164.82K | 221.04K | 184.23K | 196.81K | 210.31K | 155.59K | 99.5K | 43.39K | 38.69K | 33.49K | 6.52K | 5.97K | 4.77K | 3.89K | 4.34K |
Pretax Income | -1.79M | -2.14M | -2.57M | -1.67M | -2.64M | -2.34M | -1.96M | -3.44M | -445.9K | -2.7M | -2.82M | -4.8M | -10.13M | -4.34M | -5.46M | -3.77M | -4.03M | -3.9M | -2.87M | -1.6M |
Net Income | -1.79M | -2.14M | -2.57M | -1.67M | -2.65M | -2.34M | -1.96M | -3.44M | -448.29K | -2.7M | -2.82M | -4.81M | -10.13M | -4.34M | -5.46M | -3.77M | -4.03M | -3.9M | -2.87M | -1.6M |
Selling & General & Admin | 2.25M | 1.34M | 1.55M | 1.42M | 1.66M | 1.86M | 1.81M | 1.76M | 1.87M | 1.91M | 1.97M | 2.14M | 2.24M | 2.39M | 2.34M | 1.74M | 1.93M | 1.68M | 1.23M | 624.79K |
Research & Development | 112.69K | 919.07K | 1.06M | 768.46K | 1.65M | 891.24K | 808.27K | 1.75M | 826.31K | 1.19M | 1.14M | 1.89M | 1.93M | 2.19M | 3.23M | 1.89M | 2.12M | 2.23M | 1.2M | 911.16K |
Other Expenses | n/a | n/a | n/a | n/a | 74.9K | 74.32K | 73.21K | -3.48M | -613.1K | -2.84M | -2.94M | -4.7M | -3.85M | -4.36M | -5.43M | 36.15K | 35.43K | 34.45K | 47.01K | 27.98K |
Operating Expenses | 2.37M | 2.26M | 2.61M | 2.19M | 3.38M | 2.83M | 2.69M | 28.77K | 2.08M | 260.38K | 176.24K | -673.1K | 321.52K | 227.75K | 142.18K | 3.67M | 4.09M | 3.94M | 2.47M | 1.56M |
Interest Expense | 20.08K | n/a | 351.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 460.12K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.09M | 3.36M | 3.26M | 2.95M | 4.5M | 4.03M | 3.9M | 1.22M | 3.06M | 1.4M | 631.22K | 439.74K | 662.79K | 386.82K | 337.86K | 3.67M | 4.09M | 3.94M | 2.47M | 1.56M |
Income Tax Expense | n/a | n/a | n/a | n/a | 9.71K | n/a | n/a | n/a | 2.38K | 2.03K | 4.03K | 9.32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 975.99K | 1.1M | 706.55K | 620.13K | 891.9K | 961.3K | 778K | 332.82K | 323.08K | 332.82K | 230.05K | 86.46K | 64.39K | 56.61K | 55.39K | 48.16K | 32.18K | 30.2K | 24.37K | 20.88K |
Shares Outstanding (Diluted) | 975.99K | 1.1M | 706.55K | 620.13K | 891.9K | 961.3K | 797.35K | 332.82K | 332.82K | 332.82K | 230.05K | 86.56K | 64.41K | 56.61K | 55.39K | 48.19K | 32.18K | 30.2K | 24.37K | 20.88K |
EPS (Basic) | -1 | -2 | -4 | -3 | -2.17 | -2.4 | -2.5 | -10.4 | -1.3 | -8.1 | -12.4 | -56 | -157.3 | -76.8 | -97.8 | -78.1 | -125.5 | -129.1 | -117.2 | -102 |
EPS (Diluted) | -1 | -2 | -4 | -3 | -2.17 | -2.4 | -2.5 | -10.4 | -1.4 | -8.1 | -12.4 | -56.1 | -157.3 | -76.8 | -97.8 | -78.2 | -125.5 | -129.1 | -117.2 | -102 |
EBITDA | -1.79M | -2.08M | -2.15M | -1.69M | -2.54M | -2.13M | -1.76M | -3.35M | -483.92K | -2.71M | -2.8M | -4.57M | -9.93M | -4.23M | -5.3M | -3.6M | -3.99M | -3.83M | -2.28M | -1.54M |
EBIT | -1.84M | -2.14M | -2.2M | -1.75M | -2.75M | -2.34M | -1.96M | -3.55M | -683.92K | -2.91M | -3M | -4.77M | -10.13M | -4.42M | -5.5M | -3.67M | -4.03M | -3.9M | -2.4M | -1.56M |
Depreciation & Amortization | 52.74K | 52.85K | 53.15K | 54.39K | 207.69K | 204.48K | 202.28K | 202.27K | 200K | 201.74K | 197.99K | 203.58K | 198.36K | 191.57K | 191.13K | 68.98K | 35.43K | 69.06K | 124.98K | 27.98K |